Covid.jpg

ATLANTA – The federal government has changed the way COVID-19 monoclonal antibody treatments will be distributed in the United States, including Georgia. The decision announced Sept. 13 by the U.S. Department of Health and Human Services is the result of supply shortages and extraordinary demand for the treatments across the country, particularly due to the rapid spread of the delta variant. Health care providers will no longer be able to order the treatments directly.

HHS will determine each state’s weekly allocation of monoclonal antibody products based on use and the number of new COVID cases. The Georgia Department of Public Health will identify which sites in the state will receive the product and the amount each site receives. Healthcare providers must record their administration of the products in order to be eligible to receive additional shipments.

Recommended for you

(0) comments

Welcome to the discussion.

Please log in, or sign up for a new, free account to read or post comments.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.